Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Delate

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Thrombosis Research|March 26, 2013
Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplastyNathan P Clark, Stephanie E Cho, Thomas Delate, et al.
Journal of Opioid Management|December 19, 2019
Birth outcomes with prescribed chronic and acute opioid exposure during pregnancyThomas Delate, Megan Hodges, Morgan Swank, et al.
Pharmacy Practice|September 13, 2014
An evaluation of a clinical pharmacy-directed intervention on blood pressure controlCaroline E Kicklighter, Kent M Nelson, Tammy L Humphries, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2008
Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit thresholdAmber Cronk, Tammy L Humphries, Thomas Delate, et al.
Pharmacotherapy|March 26, 2010
Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancyNathan P Clark, Thomas Delate, Steven J Cleary, et al.
Applied Clinical Informatics|July 29, 2016
Renal Drug Dosing. Effectiveness of Outpatient Pharmacist-Based vs. Prescriber-Based Clinical Decision Support SystemsErin A Vogel, Sarah J Billups, Sheryl J Herner, et al.
Plos One|April 8, 2020
Validation of algorithms to identify elective percutaneous coronary interventions in administrative databasesCatherine G Derington, Lauren J Heath, David P Kao, et al.
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Randomized controlled trial of a dose consolidation programThomas Delate, Kathleen A Fairman, Shelly M Carey, et al.
Pharmacotherapy|July 30, 2009
Factors associated with recurrent coronary events among patients with cardiovascular diseaseKaren J McConnell, Kari L Olson, Thomas Delate, et al.
Thrombosis Research|August 25, 2009
Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancyNathan P Clark, Thomas Delate, Steven J Cleary, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Thrombosis Research|March 26, 2013
Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplastyNathan P Clark, Stephanie E Cho, Thomas Delate, et al.
Journal of Opioid Management|December 19, 2019
Birth outcomes with prescribed chronic and acute opioid exposure during pregnancyThomas Delate, Megan Hodges, Morgan Swank, et al.
Pharmacy Practice|September 13, 2014
An evaluation of a clinical pharmacy-directed intervention on blood pressure controlCaroline E Kicklighter, Kent M Nelson, Tammy L Humphries, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2008
Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit thresholdAmber Cronk, Tammy L Humphries, Thomas Delate, et al.
Pharmacotherapy|March 26, 2010
Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancyNathan P Clark, Thomas Delate, Steven J Cleary, et al.
Applied Clinical Informatics|July 29, 2016
Renal Drug Dosing. Effectiveness of Outpatient Pharmacist-Based vs. Prescriber-Based Clinical Decision Support SystemsErin A Vogel, Sarah J Billups, Sheryl J Herner, et al.
Plos One|April 8, 2020
Validation of algorithms to identify elective percutaneous coronary interventions in administrative databasesCatherine G Derington, Lauren J Heath, David P Kao, et al.
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Randomized controlled trial of a dose consolidation programThomas Delate, Kathleen A Fairman, Shelly M Carey, et al.
Pharmacotherapy|July 30, 2009
Factors associated with recurrent coronary events among patients with cardiovascular diseaseKaren J McConnell, Kari L Olson, Thomas Delate, et al.
Thrombosis Research|August 25, 2009
Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancyNathan P Clark, Thomas Delate, Steven J Cleary, et al.
Pageof 16